Ab Science
Clinical trials sponsored by Ab Science, explained in plain language.
-
New hope for slowing ALS progression in major trial
Disease control Recruiting nowThis large, late-stage trial is testing whether adding an oral drug called masitinib to the standard ALS medication riluzole can better slow the progression of the disease. The study will involve 495 adults with ALS who are already taking riluzole. Researchers aim to see if the c…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis study is testing a new drug called AB8939 for people with acute myeloid leukemia (AML) that has come back or hasn't responded to previous treatments. The main goals are to find a safe dose and see if the drug helps control the cancer. It's for patients who have already tried…
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC